Skip to main content

UBS Group AG

Position in SPRY — ARS Pharmaceuticals, Inc.

CIK 1610520 ZURICH, V8

Position in SPRY

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$18,150,409
-$7,606,177 QoQ
Shares Held
2,260,325
+2.2% QoQ
Ownership
2.28%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2020
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SPRY Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

UBS Group AG holds $8,307,109,707 across 562 Biotechnology names. SPRY ranks #75 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in SPRY

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $18,150,409 2,260,325
2025-12-31 $25,756,586 2,210,866
2025-09-30 $6,631,853 659,886
2025-06-30 $15,128,014 866,935
2025-03-31 $7,437,068 591,182
2024-12-31 $10,683,995 1,012,701
2024-09-30 $1,593,288 109,882
2024-06-30 $552,486 64,922
2024-03-31 $1,067,386 104,441
2023-12-31 $9,469 1,728
2023-03-31 $18,898 2,903
2022-09-30 $63 12
2022-06-30 $2,128 502
2022-03-31 $1,799 513
2021-12-31 $525,074 78,840
2021-09-30 $137,025 13,730
2021-06-30 $5,405 175
2021-03-31 $154,406 3,539
2020-12-31 $4,309 93